Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine.
about
Identification and assessment of tumor-oromoting and cocarcinogenic agents: state-of-the-art in vitro methodsInitiation and promotion in cancer formation: the importance of studies on intercellular communicationAge-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamineMorphologic and cytochemical properties of mouse liver neoplasms induced by diethylnitrosamine and promoted by 4,4'-dichlorodiphenyltrichloroethane, chlordane, or heptachlorPromotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effectSelective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbitalFlow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the ratChemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on CarcinogensNuclear receptor CAR represses TNFalpha-induced cell death by interacting with the anti-apoptotic GADD45BFungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer.An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.Mechanism of action of toxic halogenated aromaticsEffects of PCBs and related compounds on hepatocarcinogenesis in rats and mice.Concentration-dependent inhibition of development of GGT positive foci in rat liver by the environmental contaminant di(2-ethylhexyl) phthalate.Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis.Tumor promotion in rat liver.Epigenetic effects of liver tumor promoters and implications for health effectsQuantitative aspects of chemical carcinogenesis and tumor promotion in liver.The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.Aldehyde dehydrogenases and their role in carcinogenesis.Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAPStudies on the proliferation and fate of oval cells in the liver of rats treated with 2-acetylaminofluorene and partial hepatectomyOccurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study.Enzyme patterns in human hepatocellular carcinoma.Induction of foci of altered, gamma-glutamyltranspeptidase-positive hepatocytes in carcinogen-treated rats fed a choline-deficient diet.Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.Carcinogenicity and haemoglobin synthesis induction by cytidine analogues.Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis.Progression: the terminal stage in carcinogenesis.Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert LectureRapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis.Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells.Comparative histopathology of the development of selected neoplasms of the liver, pancreas, and urinary bladder in rodentsModels of hepatocarcinogenesis in the rat--contrasts and comparisons.Proliferative hepatocellular lesions of the rat: review and future use in risk assessment.Metabolic control mechanisms in precancerous liver.Dinitrotoluene: acute toxicity, oncogenicity, genotoxicity, and metabolism.
P2860
Q23914589-DDA8B777-3BA3-457A-BB83-653CD1CBB06FQ24650305-D895849D-E8B9-4645-A832-F756280D1E65Q28333304-F16EB5E1-DEC9-4194-AEEB-F6CCDEB1F2E6Q28336849-4BA7AEE6-AD94-4239-96CB-49E271E16B56Q28367495-3EABE54A-596B-4FCA-8347-08683DEDD4E8Q28369200-118DDADF-B488-4938-9054-4825BF7CF563Q28378753-6FBDFD16-3991-49FE-A2AB-0D19118D6890Q28768656-4C0CE133-81C2-48C7-8662-EC5AC60DA177Q33559777-25FFEE00-ABFB-43AA-A587-9292D2BA5F44Q34231467-0B67C867-75ED-492F-B126-89A408D45081Q34660156-5FAF566E-BA2F-429A-AD27-D305D1E6DDDEQ35034179-13849423-28CB-4C60-9437-14FE3666E8BEQ35034263-A2020A1E-A835-431F-A7A0-70405E905262Q35035438-BC2CC9C7-7485-46FA-8B88-D3AF7C2ECDA3Q35035516-6D95CB23-5FE2-4CE5-8924-419AC0AB7F4DQ35037119-3F15C8BA-DA26-4F2B-A966-F47727B8A7CDQ35037433-1F450567-E4A8-4304-A7B3-C86645AECABAQ35037447-26E9B064-B509-4926-88E7-21B2F5248B33Q35037495-8A955BCE-5407-46A2-9C97-47BEB124A7D7Q35037499-5BA13AE1-07D9-483B-A3F1-5AE7C50A3F04Q35815650-F2C6BE9B-9ED3-4E01-AF50-D9679D47BBC9Q35830000-3EB43DB9-2E98-4673-B273-72021AB06C4DQ35858063-F2A6021D-7B68-4717-9ADB-A80D2C935F75Q35858259-4915C7E4-D232-4A1D-A5EC-3218D06169C3Q35862947-B5A22DA5-7F18-4B27-B45C-2FDA900DBEB1Q36043267-FE82D00E-5C2B-42E7-93AE-DD0AD48DAE30Q36076338-1D884E40-31A3-48F2-A290-CD8135EB457BQ36092965-CA5FEF6D-4B8B-4C1A-932F-04AF5535A6ADQ36466174-A1D65ADD-E54D-4528-8195-EC0637BC411EQ37623769-6CE606EA-51C3-4A16-B2DC-67ED7CD28C16Q37691192-87337861-CA27-4CE7-BAC0-EE5C5FFCC62BQ38235230-3D76BDBA-E15C-481D-B7FB-AA42583B48EAQ38593507-7DB8C924-A950-496A-BD7C-89DC7F10A6CAQ38656792-DAC29E9D-E179-4E90-9AC7-C70EF5C453EAQ38834862-36E1B49B-69F8-4238-8BDF-B0266BA2DD93Q39647992-006F8A2F-2C69-49DE-87E1-C4E8B44CC0F3Q39740986-D8519955-BE01-430A-8D96-4ED762CAC0ABQ39773641-5E785056-3BCA-4B27-A400-78FBFB9240DDQ40121657-D5E38B81-2D09-4D12-8C4A-F4C0D83B1623Q40189517-4BD23DE8-78B7-4DFC-8324-1C4F3D82808F
P2860
Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@en
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@nl
type
label
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@en
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@nl
prefLabel
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@en
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@nl
P2093
P2860
P356
P1433
P1476
Biochemical characterisation o ...... le dose of diethylnitrosamine.
@en
P2093
Barsness L
Goldsworthy T
Kitagawa T
P2860
P2888
P304
P356
10.1038/271456A0
P407
P577
1978-02-01T00:00:00Z
P6179
1044115638